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SUMMARY 
Results of renal function tests done on 36 patients on prophylactic lithium treatment are compared with 
those of 28 age matched individuals, also being treated for affective disorders but exposed only to neuroleptics 
and/or tricyclic antidepressants. 25% of the lithium treated patients had A.D.H. resistant concentration dysfunc-
tion resulting in polyuria and polydypsia. Serum lithium levels had a significant positive correlation with the daily 
urine volume and a significant negative correlation with the 12 hour urine specific gravity. No relationship was 
found between the total amount of lithium consumed or the duration of lithium treatment and the urine volume. 
Though a higher proportion of the lithium treated patients had proteinuria, it was only of a mild degree. 
Glomerular Filteration Rate and renal tubular hydrogen ion excretion were normal in both the test and control 
groups. 
Introduction 
Lithium therapy is widely used in the 
treatment and prophylaxis of recurrent af-
fective illness (Coppen et al. 1971). 
Lithium is eliminated from the body by the 
kidneys and is concentrated in the renal 
medulla (Cox & Singer 1981), cir-
cumstances that are favourable to the oc-
curance of drug induced renal disease. A 
number of nephro-toxic effects like nat-
riuresis (Saran & Russel 1976), 
hypokalemia (Angrist et al. 1970), renal 
tubular acidosis (Cox and Singer 1981), 
polyuria which does not respond to an-
tidiuretic hormone (A.D.H.) (Angrist et 
al. 1976; Cox & Singer, 1975 & 1981), low 
glomerular filtration rate (Hestbech et al, 
1977; Vestergahrd et al. 1979). proteinuria 
(Moskovitz ct al 1981) and morphological 
changes like glomerular sclerosis and in-
terstitial fibrosis (Hestbech et al. 1977; 
Venkoba Rao. 1981) have been reported 
in patients on lithium treatment. 
On the other hand, Kinacaid - Smith 
et al. (1979) have found as many lesions in 
a control group of people with similar 
psychiatric disorders who have recieved a 
multitude of psychotropic drugs other than 
lithium as in patients who received lithium 
as well as psychotropic drugs and hence the 
psychotropic drugs were held responsible 
for the renal lesions. A comparative study 
by Hullin et al. (1979) between lithium 
treated and control patients (on psychot-
ropic drugs other than lithium) failed to re-
veal any significant renal impairment in 
the lithium group. 
The aim of the present study was to 
compare a group of patients with affective 
disorders who had never received lithium 
with patients treated with lithium and 
psychotropic drugs in such a way th.it the 
psychotropic drugs (other than lithium) 
would not affect the comparative findings. 
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Material and Methods 
Sixtyfour consenting patients with 
manic depressive psychoses (diagnosed on 
the guidelines of ICD 9 - 1977) belonging 
to both sexes and between 22 and 55 years 
of age, attending the lithium clinic at 
Christian Medical College & Hospital, 
Vellore, were included in the study. All 
possible causes ot renal dysfunction were 
excluded and those with diabetes mellitus, 
hypertension, autoimmune diseases or 
known renal diseases were excluded from 
the study. In all these patients, physical 
examination, serum creatinine, blood 
urea, qualitative test of urine for albumin, 
sugar and the microscopical examination 
were done prior to starting them on medi-
cation and were found to be within the nor-
mal limits. Medical and psychiatric charts 
were reviewed to note lithium toxic 
episodes if any, and to record the serum 
lithium levels, the duration and the total 
amount of lithium consumed. 
The test group consisted of 36 patients 
on prophylactic lithium carbonate treat-
ment for a period of 25.6 ± 23.1 months, 
who were also exposed to neuroleptics, 
and/or tricyclic antidepressants prior to the 
commencement of lithium therapy and 
also along with lithium in the initial phase 
of lithium treatment. The control group 
was 28 age matched patients who never 
had received lithium but were taking 
neuroleptics and/or tricyclic antidepres-
sants for a minimum period of 6 months. 
Variation in the duration of treatment in 
the experimental and control groups were 
unavoidable because lithium was intro-
duced as a prophylactic treatment only in 
those with frequent recurrences of mania 
and/or depression while the control group 
consisted of those with first or infrequent 
episode of mania or depression, where re-
latively short term treatment with 
neuroleptics or antidepressants was suffi-
cient to control an index episode. At the 
time of this study, none of these patients 
were acutely ill and were cooperative for 
the procedures. 
Renal function tests done were as follows: 
1. Twentyfour hour urine volume. 
Patients were given verbal and written 
instructions about collecting 24 hour 
urine specimen. 
2. Twelve hour fluid deprivation test. 
Specific gravity of urine was tested by 
the hydrometer method, after fluid de-
privation for 12 hours. 
3. Vasopression (A. D. H.) Test. 
Whenever the 12 hour fluid deprivation 
test showed a specific gravity of less 
than 1020, the tubules' ability to con-
centrate was tested by giving Inj. Vas-
opression Tannate in oil, intramuscu-
larly, after the urine was voided com-
pletely. U rine was collected for the next 
4 hours and the specific gravity was 
measured. 
4. Twentyfour hour urinary protein excre-
tion. 
Values above 150 mg. were considered 
significant. 
5. Tests of Glomerulter Filtration Rate 
i) Serum creatinine - value above 
1.4 mg% was considered abnor-
mal. 
ii) The classical creatinine clearance, 
which requires 24 hour urine col-
lections, was corrected for body 
surface area and compared with the 
reported average 24 hour 
creatinine clearance values of 
84 ml/min. in normal Indian sub-
jects (Shah & Trivedi 1974). 
iii) Ideal creatinine clearance, calcu-
lated by the method of Cockroft 
and Gault (1976), which is based on 
age, weight and serum creatinine. 
This was compared with the classi-
cal creatinine clearance, so that it 
would minimise the error from im-
proper urine collection. It was con-KURUVILLA MATHEW ET AL.  35 
sidered that a patient has low GFR, 
if the classical as well as the calcu-
lated Cockroft creatinine clearance 
values were on or below the fifth 
percentile of the normal value. 
Other tests used to assess renal 
functions were estimation of (6) 
Urine pH (7) Plasma bicarbonate 
(8) Serum sodium and potassium 
(9) Qualitative examination of 
urine for albumin and sugar and 
(10) Microscopic examination of 
the centrifuged urine sediment. 
Current serum lithium levels were es-
timated by the flame photometry method. 
All patients were specifically enquired for 
the presence or absence of excessive thirst 
and passing large volume of urine. 
Results 
The mean urine volume of the lithium 
treated patients was significantly higher 
and the mean specific gravity was lower 
than the control group. Nine (25%) out of 
the 11 polyuric (more than 3000 ml/day) 
patients in the lithium treated group had 
vasopressin resistant concentration dys-
function (Table). Twenty subjects of the 
test group had urine specific gravity of less 
than 1020, of which 14 of them showed re-
sistance to the vasopressin test. One 
among the latter had a high serum sodium 
level (150 mEq/L). The 24 hour urine pro-
tein excretion ranged from 37 to 219 mg. in 
the control and 50 to 420 mg. in the test 
group. 
All those who have complained of ex-
cessive thirst and passing large volumes of 
urine had polyuria. 
The creatinine clearance values, mea-
sured by the Classical and Cockroft 
methods did not differ significantly in 
either of the groups (Control group-paired 
t = 1.99 N.S. ; test group-paired t = 1.59 
N.S.). None of the patients had a GFR 
measured by the Classical as well as the 
Cockroft method, on or below the fifth 
percentile of the normal value (84 ml/min). 
None of the patients had a serum 
creatinine level above the normal range. 
Urine pH and plasma bicarbonate levels 
were within normal limits in ail these sub-
jects. 
The routine qualitative assessment of 
urine for albumin and sugar and the mic-
roscopical examination of the centrifuged 
urinary sediments were within the normal 
limits. 
The serum lithium levels ranged from 
0.5 to 1.4 mEq/L (Mean ± S.D. = 0.87 ± 
0.22 mEq/L). None of the patients had 
episodes of lithium toxicity during their 
course of treatment. The mean amount of 
lithium consumption was 809 ± 814.87 gms 
(Range 81 to 3450 Gms). 
There was no significant correlation 
between the daily urine volume of the test 
group and the total amount of lithium con-
sumed (r = 0.12) or the duration of lithium 
therapy (r = 0.58). Similarly there was no 
significant correlation between the 12 hour 
fluid deprivation specific gravity values 
and the total lithium consumption (r = 
0.14) or the duration of lithium therapy 
(r = 0.045). However the serum lithium 
levels showed a significant positive corre-
lation with the daily urine volumes (r = 
0.739 ; p = 0.001) (Figure 1) and a signific-
ant negative correlation with the 12 hour 
specific gravity (r = 0.638; p = 0.001) (Fi-
gure 2). 
Discussion 
The present study suggests that 
lithium has a polydipsic polyuric action. 
Twentyfive percent of the lithium treated 
patients had an A.D.H. resistant polyuria. 
The present study confirms the previous 
reports of an impaired concentrating 36  RENAL FUNCTION TESTS IN LITHIUM TREATED PATIENTS 
Table 
Comparison of Renal Functions of Patients witn and without Lithium Therapy 
Renal Function Tests  Control Group 
n = 28 
Test Group 
n = 36 
Differences between 
Control & Test Groups 
24 hour Urine Volume 
Mean±S.D. 
Number of cases 
with polyuria 
12 hour specific Gravity 
Mean±S.D. 
Number of cases with vasopressin 
resistant concentration defect 
24 hour urine protein Mean + S.D. 
Number of patients with proteinuria 
of 150 mg./day 
1518 + 1028.3 
1 
1025 ±8.45 
2 
99 ± 47.7 
5 
2525 ± 1207.8 
11 
1010 ±8.16 
14 
160 ±94.3 
18 
p< 0.001* 
p<0.05* 
p<0.01* 
p<0.01* 
p<0.01* 
p<0.05* 
* = Significant 
0-6 01 10 1-2 |.« 
Serum lithium ( milli equivoltnts/ titr*) 
(r - 0.739; p = 0.001) 
1032 
102* 
t 
1024 
1020 
i 
' 101* 
i 
1012 
100*  T  -t—f- -f—f- -1T 1 1 
0-8 0-6 07 0-8 0-» 1.0 1.1 1-2 t.J !•« 1-8 
Scrum lithium (millivquivalffnts/litre) 
(r - 0.638; p- 0.001) 
Figure 1  Figure 2 
capacity in lithium treated patients (Bucht 
and Wahlin 1980; Venkoba Rao 1979). 
A few patients with A.D.H. resistant 
concentration dysfunction did not have 
their daily urine volume exceeding 3 litres. 
It could probably, be due to an improper 
collection of urine. 
It is interesting to note that there is a 
positive correlation between the serum 
lithium values and the daily urine volumes KURUVILLA MATHEW ET AL.  37 
and a correspondingly negative correlation 
with the specific gravities. 
This study could not establish any re-
lationship between the total amount of 
lithium consumed or the duration of 
lithium treatment and the urine volume. 
This finding is in agreement with the ear-
lier reports that polydipsia and polyuria 
are seen during the initial period of inges-
tion, and also appear or reappear as late 
side effects after months or years of lithium 
treatment (Shopsin & Gershon 1973). 
The observation that all those lithium 
treated patients, who complained of exces-
sive thirst and passing large volumes of 
urine had polyuria has some practical im-
plications. 
1. Such patients are likely to have a drug 
induced concentration defect. 
2. Those complaints are clinical indicators 
for frequent monitoring of their renal 
functions. 
Hypernatremia detected in one of the 
lithium treated patients (Na = 150 mEq/L) 
could probably have resulted from the 
A.D.H. resistant polyuria observed in this 
patient. 
A higher proportion of a mild degree 
of proteinuria was observed in the lithium 
group, though none of them had gross 
poteinuria. Hullin and associates (1979) 
studied patients on long term lithium treat-
ment and compared them with an age and 
sex matched group of psychiatric patients 
who were taking other psychotropic drugs. 
No significant differences in Beta-2-mic-
roglobulin excretion (an indicator of renal 
tubular damage) was found. In the present 
study, we have not employed the sophisti-
cated tests for detecting renal tubular dys-
function. Similarly, histopathological 
examination was not done, as the observed 
abnormalities in the renal function test did 
not warrant an invasive procedure like 
renal biopsy. 
The glomerular function as measured 
by G.F.R. has been found normal in both 
the groups. Recently published studies 
vary widely in the quantitative assessment 
of G.F.R. in lithium treated patients. Our 
observation is consistent with that of many 
other investigators (Gerner et al 1980, 
Venkoba Rao 1979, Vestergaard et al. 
1979). 
None of our subjects had defective 
renal tubular Hydrogen ion excretion as 
measured by the urine pH and plasma 
bicarbonate levels. An incomplete renal 
tubular acidosis has been reported among 
lithium treated patients (Perezet al. 1975). 
Viol (1975) found normal urinary acidifi-
cation in all the 10 lithium treated patients 
he studied, in response to ammonium 
chloride ingestion. 
There are a few limitations in the pre-
sent study. First, the number of patients 
studied, is relatively small when compared 
to the previous studies and for this reason, 
we did not attempt to differentiate the pos-
sible minor variation between the male 
and female subjects. Second, this study is 
cross sectional in design and is lacking all 
the data on renal functions before the initi-
ation of lithium therapy. 
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